Cargando…
Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy
BACKGROUND: Duchenne muscular dystrophy (DMD) leads to progressive cardiomyopathy. Detection of myocardial fibrosis with late gadolinium enhancement (LGE) by cardiovascular magnetic resonance (CMR) is critical for clinical management. Due to concerns of brain deposition of gadolinium, non-contrast m...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082768/ https://www.ncbi.nlm.nih.gov/pubmed/33910579 http://dx.doi.org/10.1186/s12968-021-00736-1 |
_version_ | 1783685902635106304 |
---|---|
author | Raucci, Frank J. Xu, Meng George-Durrett, Kristen Crum, Kimberly Slaughter, James C. Parra, David A. Markham, Larry W. Soslow, Jonathan H. |
author_facet | Raucci, Frank J. Xu, Meng George-Durrett, Kristen Crum, Kimberly Slaughter, James C. Parra, David A. Markham, Larry W. Soslow, Jonathan H. |
author_sort | Raucci, Frank J. |
collection | PubMed |
description | BACKGROUND: Duchenne muscular dystrophy (DMD) leads to progressive cardiomyopathy. Detection of myocardial fibrosis with late gadolinium enhancement (LGE) by cardiovascular magnetic resonance (CMR) is critical for clinical management. Due to concerns of brain deposition of gadolinium, non-contrast methods for detecting and monitoring myocardial fibrosis would be beneficial. OBJECTIVES: We hypothesized that native T1 mapping and/or circumferential (ε(cc)) and longitudinal (ε(ls)) strain can detect myocardial fibrosis. METHODS: 156 CMRs with gadolinium were performed in 66 DMD boys and included: (1) left ventricular ejection fraction (LVEF), (2) LGE, (3) native T1 mapping and myocardial tagging (ε(cc-tag) measured using harmonic phase analysis). LGE was graded as: (1) presence/absence by segment, slice, and globally; (2) global severity from 0 (no LGE) to 4 (severe); (3) percent LGE using full width half maximum (FWHM). ε(ls) and ε(cc) measured using feature tracking. Regression models to predict LGE included native T1 and either ε(cc-tag) or ε(ls) and ε(cc) measured at each segment, slice, and globally. RESULTS: Mean age and LVEF at first CMR were 14 years and 54%, respectively. Global ε(ls) and ε(cc) strongly predicted presence or absence of LGE (OR 2.6 [1.1, 6.0], p = 0.029, and OR 2.3 [1.0, 5.1], p = 0.049, respectively) while global native T1 did not. Global ε(cc), ε(ls), and native T1 predicted global severity score (OR 2.6 [1.4, 4.8], p = 0.002, OR 2.6 [1.4, 6.0], p = 0.002, and OR 1.8 [1.1, 3.1], p = 0.025, respectively). ε(ls) correlated with change in LGE by severity score (n = 33, 3.8 [1.0, 14.2], p = 0.048) and ε(cc-tag) correlated with change in percent LGE by FWHM (n = 34, OR 0.2 [0.1, 0.9], p = 0.01). CONCLUSIONS: Pre-contrast sequences predict presence and severity of LGE, with ε(ls) and ε(cc) being more predictive in most models, but there was not an observable advantage over using LVEF as a predictor. Change in LGE was predicted by ε(ls) (global severity score) and ε(cc-tag) (FWHM). While statistically significant, our results suggest these sequences are currently not a replacement for LGE and may only have utility in a very limited subset of DMD patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12968-021-00736-1. |
format | Online Article Text |
id | pubmed-8082768 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80827682021-04-29 Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy Raucci, Frank J. Xu, Meng George-Durrett, Kristen Crum, Kimberly Slaughter, James C. Parra, David A. Markham, Larry W. Soslow, Jonathan H. J Cardiovasc Magn Reson Research BACKGROUND: Duchenne muscular dystrophy (DMD) leads to progressive cardiomyopathy. Detection of myocardial fibrosis with late gadolinium enhancement (LGE) by cardiovascular magnetic resonance (CMR) is critical for clinical management. Due to concerns of brain deposition of gadolinium, non-contrast methods for detecting and monitoring myocardial fibrosis would be beneficial. OBJECTIVES: We hypothesized that native T1 mapping and/or circumferential (ε(cc)) and longitudinal (ε(ls)) strain can detect myocardial fibrosis. METHODS: 156 CMRs with gadolinium were performed in 66 DMD boys and included: (1) left ventricular ejection fraction (LVEF), (2) LGE, (3) native T1 mapping and myocardial tagging (ε(cc-tag) measured using harmonic phase analysis). LGE was graded as: (1) presence/absence by segment, slice, and globally; (2) global severity from 0 (no LGE) to 4 (severe); (3) percent LGE using full width half maximum (FWHM). ε(ls) and ε(cc) measured using feature tracking. Regression models to predict LGE included native T1 and either ε(cc-tag) or ε(ls) and ε(cc) measured at each segment, slice, and globally. RESULTS: Mean age and LVEF at first CMR were 14 years and 54%, respectively. Global ε(ls) and ε(cc) strongly predicted presence or absence of LGE (OR 2.6 [1.1, 6.0], p = 0.029, and OR 2.3 [1.0, 5.1], p = 0.049, respectively) while global native T1 did not. Global ε(cc), ε(ls), and native T1 predicted global severity score (OR 2.6 [1.4, 4.8], p = 0.002, OR 2.6 [1.4, 6.0], p = 0.002, and OR 1.8 [1.1, 3.1], p = 0.025, respectively). ε(ls) correlated with change in LGE by severity score (n = 33, 3.8 [1.0, 14.2], p = 0.048) and ε(cc-tag) correlated with change in percent LGE by FWHM (n = 34, OR 0.2 [0.1, 0.9], p = 0.01). CONCLUSIONS: Pre-contrast sequences predict presence and severity of LGE, with ε(ls) and ε(cc) being more predictive in most models, but there was not an observable advantage over using LVEF as a predictor. Change in LGE was predicted by ε(ls) (global severity score) and ε(cc-tag) (FWHM). While statistically significant, our results suggest these sequences are currently not a replacement for LGE and may only have utility in a very limited subset of DMD patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12968-021-00736-1. BioMed Central 2021-04-29 /pmc/articles/PMC8082768/ /pubmed/33910579 http://dx.doi.org/10.1186/s12968-021-00736-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Raucci, Frank J. Xu, Meng George-Durrett, Kristen Crum, Kimberly Slaughter, James C. Parra, David A. Markham, Larry W. Soslow, Jonathan H. Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy |
title | Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy |
title_full | Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy |
title_fullStr | Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy |
title_full_unstemmed | Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy |
title_short | Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy |
title_sort | non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in duchenne muscular dystrophy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082768/ https://www.ncbi.nlm.nih.gov/pubmed/33910579 http://dx.doi.org/10.1186/s12968-021-00736-1 |
work_keys_str_mv | AT rauccifrankj noncontrastcardiovascularmagneticresonancedetectionofmyocardialfibrosisinduchennemusculardystrophy AT xumeng noncontrastcardiovascularmagneticresonancedetectionofmyocardialfibrosisinduchennemusculardystrophy AT georgedurrettkristen noncontrastcardiovascularmagneticresonancedetectionofmyocardialfibrosisinduchennemusculardystrophy AT crumkimberly noncontrastcardiovascularmagneticresonancedetectionofmyocardialfibrosisinduchennemusculardystrophy AT slaughterjamesc noncontrastcardiovascularmagneticresonancedetectionofmyocardialfibrosisinduchennemusculardystrophy AT parradavida noncontrastcardiovascularmagneticresonancedetectionofmyocardialfibrosisinduchennemusculardystrophy AT markhamlarryw noncontrastcardiovascularmagneticresonancedetectionofmyocardialfibrosisinduchennemusculardystrophy AT soslowjonathanh noncontrastcardiovascularmagneticresonancedetectionofmyocardialfibrosisinduchennemusculardystrophy |